Tag: cessation

  • VA, DoD Update Cessation Recommendations

    VA, DoD Update Cessation Recommendations

    The U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) issued updated clinical practice guidelines for treating tobacco and nicotine use among veterans and military service members. Published in the Annals of Internal Medicine, the guideline includes 32 recommendations covering cessation medications, counseling approaches, and treatment strategies for adults who use a range of tobacco and nicotine products. The guideline recommends varenicline or combination nicotine replacement therapy (NRT) to increase abstinence, motivational interviewing to improve treatment engagement, and immediate retreatment following relapse.

    The guideline, which is based on literature published through 2024, also addresses electronic nicotine delivery systems, including e-cigarettes, but does not recommend them as a cessation treatment, stating that evidence is insufficient to establish their efficacy and that known and unknown harms outweigh potential benefits. Nicotine pouches and other newer nicotine products are included within the guideline’s broader scope of tobacco and nicotine use, but the recommendations do not endorse them as cessation treatments. The guideline also recommends offering treatment to adults who are not yet ready to quit and supports pharmacotherapy for patients with mental health conditions, citing evidence of safety and effectiveness.

  • FDA Releases New Smoking Cessation Posters

    FDA Releases New Smoking Cessation Posters

    The U.S. Food and Drug Administration’s Center for Tobacco Products has released new posters encouraging adults who smoke cigarettes to keep trying to quit. The free materials feature positive, motivational messages and direct smokers to EveryTryCounts.gov, a cessation website developed with the National Cancer Institute that offers online counseling and quitting resources. The posters are available to healthcare professionals, community organizations, and other stakeholders to order, download, and print through FDA’s Tobacco Education Resource Library.

  • Experts Recommend Physicians Use Vape to Help Smokers Quit

    Experts Recommend Physicians Use Vape to Help Smokers Quit

    Researchers from the Society for Research on Nicotine and Tobacco Treatment Network published new recommendations in the JAMA encouraging healthcare providers to discuss nicotine e-cigarettes as a potential harm reduction option for adults who smoke and have been unable or unwilling to quit using FDA-approved cessation methods. The guidance, published July 30, emphasizes patient-centered, shared decision-making and is intended only for adults who smoke, not for youth or non-tobacco users. The authors stress that completely quitting combustible cigarettes remains the preferred outcome and that adults who switch to e-cigarettes should fully replace cigarette smoking rather than continue dual use.

    Among the authors is Patricia Cioe, professor and associate dean for research and scholarship at the University of Rhode Island College of Nursing, who was the only nurse scientist on the expert panel. Cioe said her perspective on tobacco harm reduction evolved through years of clinical practice and research, including interviews with adults who described repeated unsuccessful quit attempts despite strong motivation to stop smoking. She said those experiences underscored the need for clinicians to “meet patients where they are” by discussing all evidence-based options that may reduce the harms of continued cigarette smoking.

    The recommendations reflect growing discussion within the medical community around tobacco harm reduction while reaffirming that smoking cessation remains the optimal health goal. The authors say clinicians should individualize treatment conversations based on each patient’s circumstances, particularly for smokers who have not succeeded with conventional cessation therapies.

  • THR Needed for HIV Care, Researcher Says  

    THR Needed for HIV Care, Researcher Says  

    Dr. Jonathan Shuter, an infectious disease physician at Montefiore Einstein and professor of medicine at Albert Einstein College of Medicine in New York, said in an interview with TheBodyPro that smoking-related illnesses now kill more people living with HIV in the United States than the virus itself. He said smoking rates among people with HIV remain around 40% — far higher than in the general population — and that cessation programs have produced disappointing results, with only about one in five smokers successfully quitting.

    Shuter argued that clinicians should adopt a broader harm reduction approach that supports patients who reduce smoking even if they do not quit completely, while emphasizing lung cancer screening, cardiovascular risk management, and tailored interventions that address the different reasons people with HIV smoke. Shuter also said complete switching from cigarettes to vaping could reduce harm compared with smoking, but cautioned that dual use of cigarettes and e-cigarettes offers little health benefit and remains the more common pattern among people living with HIV.

  • German Study Finds Strict Laws Don’t Equate to Cessation Success

    German Study Finds Strict Laws Don’t Equate to Cessation Success

    An international study by the German Cancer Research Center analyzing more than 50,000 smokers across 29 countries found that while stronger tobacco control policies—such as taxes, warning labels, and smoking bans—significantly increase quit attempts, long-term success is driven largely by individual and social factors. The research showed that smokers living with other smokers or exhibiting higher nicotine dependence were substantially less likely to quit successfully, regardless of policy environment.

    Researchers said the findings highlight a gap between policy impact and behavioral outcomes, indicating that regulatory measures can prompt quitting efforts but do not guarantee cessation. The study concludes that outcomes are heavily influenced by personal environment, including household smoking behavior and addiction levels, suggesting that cessation success varies widely even in markets with strict tobacco control frameworks.

  • Dutch Insurance to Cover Three Attempts to Quit Smoking per Year

    Dutch Insurance to Cover Three Attempts to Quit Smoking per Year

    New health insurance guidelines in the Netherlands that took effect January 1 allow smokers to receive reimbursement for up to three quit attempts per year, a move public health advocates say could significantly boost long-term cessation rates. Data show smokers enrolled in support programs are six times more likely to remain smoke-free for a year, with success rates rising to nearly 30% in the most intensive programs. Despite decades of decline, smoking still affects about 18% of the population—rising to 30% among those with lower education levels—and experts note it takes an average of six attempts to quit for good. While stop-smoking courses cost around €400 per attempt, campaigners argue the expense is outweighed by potential healthcare savings, with studies estimating billions in avoided medical costs and tens of thousands of cancer cases prevented if smoking rates fall sharply over the next decade.

  • Türkiye Working to Cut Smoking Rate

    Türkiye Working to Cut Smoking Rate

    Türkiye’s Health Minister Kemal Memişoğlu said that smoking remains one of the country’s most serious public health challenges, with nearly one in three people using tobacco. Speaking in Ankara, he called for urgent action to reduce smoking rates and said Türkiye should no longer rank among Europe’s heaviest-smoking nations.

    Memişoğlu said Türkiye is among the world’s top three countries for lung cancer cases, and stressed that most smokers want to quit and outlined expanded government efforts, including free smoking cessation services, mobile clinics in public spaces, and counseling and medication offered through family health and healthy life centers.

    The minister also highlighted broader investments in preventive healthcare, including the expansion of family health centers and healthy life centers focused on early diagnosis, screenings, and lifestyle guidance.

  • Effected Oral Bacteria Could be Harnessed for Cessation: Study

    Effected Oral Bacteria Could be Harnessed for Cessation: Study

    A study by Dr. Nishant Mehta, associate professor at PGIMER (Postgraduate Institute of Medical Education and Research), Chandigarh, India, found that prolonged use of smokeless tobacco alters the oral microbiome, promoting the growth of bacteria capable of breaking down nicotine. The research suggests these “nicotinophilic” microbes adapt to repeated nicotine exposure by using it as an energy source. The findings indicate that these microbial changes could potentially be harnessed to support future tobacco cessation strategies.

    Presented at the 29th IAPHD National Conference (NATCON 2025) in Mangaluru, the study earned the Best Paper Award. Researchers analyzed saliva samples from smokeless tobacco users using advanced molecular techniques and confirmed that certain oral bacteria can actively metabolize nicotine. While further research is needed, experts say the study offers a new biological perspective on nicotine dependence and oral health.

  • Study: Health Risks of Chewing Tobacco Need More Attention

    Study: Health Risks of Chewing Tobacco Need More Attention

    A new global study published by Nature Communications said that chewing tobacco should be receiving more attention for the significant health risks it causes, linking it to multiple forms of cancer and stroke (evidence for heart disease remains limited). Researchers found sufficient evidence connecting chewing tobacco use to six major health outcomes—including esophageal, lip and oral cavity, laryngeal, nasopharyngeal, and other pharynx cancers, as well as stroke. These findings reinforce previous evidence that chewing tobacco is a carcinogen and highlight its growing health impact, particularly in South Asia, where over 80% of the world’s 273 million users reside.

    The study said its systematic review and meta-analysis, which analyzed over five decades of research, is the most comprehensive evaluation to date focused specifically on chewing tobacco, distinct from other smokeless tobacco products. The study’s authors called for urgent policy action to integrate chewing tobacco into global and national tobacco control programs, improve cessation support, and expand high-quality research.

  • Connecticut Votes to Nearly Triple Budget in Tobacco Fight

    Connecticut Votes to Nearly Triple Budget in Tobacco Fight

    Connecticut’s Public Health Committee approved legislation to put $32 million into the Tobacco and Health Trust Fund for smoking cessation, a $20 million increase over the proposed budget from Gov. Ned Lamont. In 2023, the state invested $12 million into the program but it was suspended in 2024.

    The money to fund this program comes from the Tobacco Master Settlement agreement. Chris Collibee, budget spokesman for the Lamont administration, said the state will receive $109.6 million from the settlement in 2025, and $108.1 million in 2026. He also said each year $200,000 of the settlement money goes to the Attorney General’s office and the Department of Revenue Services to cover the costs of tobacco enforcement, with the rest going to the General Fund.

    The Connecticut Department of Public Health found that in 2023, 12.7% of high school students used a form of tobacco, down from 18.8% in 2022.